Royce & Associates’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Buy
584,011
+166,921
+40% +$3.69M 0.11% 295
2025
Q4
$10.1M Sell
417,090
-54,839
-12% -$1.43M 0.1% 299
2025
Q3
$12M Sell
471,929
-49,876
-10% -$1.18M 0.12% 255
2025
Q2
$11.2M Sell
521,805
-338,939
-39% -$7.64M 0.12% 256
2025
Q1
$19.7M Buy
860,744
+83,462
+11% +$2.2M 0.21% 142
2024
Q4
$20.2M Sell
777,282
-47,851
-6% -$1.19M 0.19% 159
2024
Q3
$20.7M Sell
825,133
-87,519
-10% -$2.07M 0.19% 153
2024
Q2
$19.6M Buy
912,652
+397,445
+77% +$7.71M 0.18% 157
2024
Q1
$9.56M Sell
515,207
-356,396
-41% -$6.23M 0.09% 344
2023
Q4
$14.2M Buy
871,603
+628,827
+259% +$8.02M 0.13% 212
2023
Q3
$3.35M Buy
+242,776
New +$3.83M 0.03% 561
2022
Q4
Sell
-21,600
Closed -$491K 915
2022
Q3
$491K Sell
21,600
-200
-0.9% -$4.28K 0.01% 819
2022
Q2
$301K Buy
+21,800
New +$320K ﹤0.01% 884
2022
Q1
Sell
-57,300
Closed -$2.14M 964
2021
Q4
$2.14M Sell
57,300
-129,856
-69% -$5.57M 0.02% 718
2021
Q3
$7.92M Buy
187,156
+1,960
+1% +$94.4K 0.06% 481
2021
Q2
$8.24M Sell
185,196
-116,300
-39% -$4.1M 0.06% 480
2021
Q1
$10.9M Sell
301,496
-543,620
-64% -$21.5M 0.07% 419
2020
Q4
$33.7M Hold
845,116
0.28% 81
2020
Q3
$24.5M Buy
845,116
+165,500
+24% +$3.57M 0.26% 91
2020
Q2
$11.1M Buy
679,616
+198,900
+41% +$2.74M 0.12% 235
2020
Q1
$4.57M Buy
480,716
+260,000
+118% +$3.57M 0.06% 399
2019
Q4
$3.57M Buy
220,716
+24,061
+12% +$391K 0.03% 570
2019
Q3
$3.27M Buy
196,655
+10,000
+5% +$188K 0.03% 585
2019
Q2
$3.16M Buy
+186,655
New +$3.25M 0.03% 612

Other funds holding BLFS